Moreover, LSEC targeting overcomes a roadblock to gene therapy of von Willebrand disease caused by the inability of hepatocytes to multimerize von Willebrand factor protein, which is required for long-term functionality58,59. The gene discussed is VWF; the disease is platelet-type von Willebrand disease.